Home
About
Overview
Sharing Data
ORCID
Help
History (23)
A t(2;8) balanced translocation with breakpoints near the human HOXD complex causes mesomelic dysplasia and vertebral defects.
Co-Principal Investigator
Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results.
Principal Investigator
Targeting interleukin 23 for Crohn's disease: finding the right drug for the right patient.
See All 23 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting interleukin 23 for Crohn's disease: finding the right drug for the right patient.
Targeting interleukin 23 for Crohn's disease: finding the right drug for the right patient. Lancet. 2017 04 29; 389(10080):1671-1672.
View in:
PubMed
subject areas
Crohn Disease
Humans
Interleukin-23
Interleukin-6
authors with profiles
Stephen B. Hanauer